share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K:重大事件
美股SEC公告 ·  2024/09/19 04:57

牛牛AI助理已提取核心訊息

Intelligent Bio Solutions has entered into an At The Market (ATM) Offering Agreement with Ladenburg Thalmann & Co. Inc. on September 18, 2024. Under the agreement, the company may sell shares of its common stock through Ladenburg with an aggregate sales price of up to $3 million. The proceeds will be used for working capital and general corporate purposes.The sales will be conducted under the company's effective S-3 shelf registration statement and related prospectus supplement. Ladenburg will receive a 3% commission on gross proceeds from share sales and up to $75,000 in initial legal fees, plus ongoing diligence fees. The offering will be made through at-the-market sales or privately negotiated transactions.Either party can terminate the agreement with notice - five business days for the company or two business days for Ladenburg. The company is not obligated to make any sales, and actual sales will depend on market conditions and capital needs. The offering will terminate upon reaching the aggregate amount or earlier termination by either party.
Intelligent Bio Solutions has entered into an At The Market (ATM) Offering Agreement with Ladenburg Thalmann & Co. Inc. on September 18, 2024. Under the agreement, the company may sell shares of its common stock through Ladenburg with an aggregate sales price of up to $3 million. The proceeds will be used for working capital and general corporate purposes.The sales will be conducted under the company's effective S-3 shelf registration statement and related prospectus supplement. Ladenburg will receive a 3% commission on gross proceeds from share sales and up to $75,000 in initial legal fees, plus ongoing diligence fees. The offering will be made through at-the-market sales or privately negotiated transactions.Either party can terminate the agreement with notice - five business days for the company or two business days for Ladenburg. The company is not obligated to make any sales, and actual sales will depend on market conditions and capital needs. The offering will terminate upon reaching the aggregate amount or earlier termination by either party.
智能生物解決方案公司於2024年9月18日與Ladenburg Thalmann & Co. Inc.簽署了市場出售(ATM)協議。根據該協議,公司可以通過Ladenburg出售最多價值300萬美元的普通股。所籌集的資金將用於營運資金和一般企業用途。銷售將根據公司有效的S-3貨架登記聲明及相關招股說明書補充條款進行。Ladenburg將從股票銷售的毛收入中獲得3%的佣金,以及至多75,000美元的初始法律費用,外加持續的盡職調查費用。該發行將通過市場銷售或私下協商交易進行。任何一方均可提前通知終止協議——公司需提前五個工作日通知,Ladenburg需提前兩個工作日通知。公司並無義務進行任何銷售,實際銷售將取決於市場狀況和資金需求。該發行將在達到總金額或任一方提前終止時結束。
智能生物解決方案公司於2024年9月18日與Ladenburg Thalmann & Co. Inc.簽署了市場出售(ATM)協議。根據該協議,公司可以通過Ladenburg出售最多價值300萬美元的普通股。所籌集的資金將用於營運資金和一般企業用途。銷售將根據公司有效的S-3貨架登記聲明及相關招股說明書補充條款進行。Ladenburg將從股票銷售的毛收入中獲得3%的佣金,以及至多75,000美元的初始法律費用,外加持續的盡職調查費用。該發行將通過市場銷售或私下協商交易進行。任何一方均可提前通知終止協議——公司需提前五個工作日通知,Ladenburg需提前兩個工作日通知。公司並無義務進行任何銷售,實際銷售將取決於市場狀況和資金需求。該發行將在達到總金額或任一方提前終止時結束。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。